Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Chicago Medical Malpractice Lawyer Blog

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Personal Injury Law

: Chicago Medical Malpractice Lawyer Blog

FDA questions effectiveness of weight loss pill

By Hurley, McKenna & Mertz

ADVERTISEMENTS

The Food and Drug Administration says ?a pill to treat obesity from Orexigen Therapeutics Inc. helped patients lose weight, though it didn't meet all the criterion set forth by the agency.? (Washington AP, 12/3). As obesity is becoming an epidemic in America, the drug must be both effective and safe.

The drug, Contrave, is the third weight loss pill to be studied by the FDA this year, and the two others were rejected by the agency due to safety concerns. The potential issue with Contrave is that although patients taking the pill showed an average loss of 4.2% more weight than a placebo, the FDA has guidelines stating there should be at least a 5 percent difference between the drug and the placebo. The FDA will now ask a group of experts to evaluate the date and vote on the safety and efficacy of Contrave.

As a medical malpractice lawyer in Chicago, I am hopeful that the FDA considers all possible safety issues before approving a drug.

Full post as published by Chicago Medical Malpractice Lawyer Blog on December 06, 2010 (boomark / email).